MTB vs NMRA · P/E 12, rev $860.0M vs $283.5M cap
M&T Bank Corporation (MTB) versus Neumora Therapeutics, Inc. (NMRA) — a side-by-side from cached financials, not a winner call.
M&T Bank Corporation (MTB) is a banks - regional company listed on US.
Neumora Therapeutics, Inc. (NMRA) is a biotechnology company listed on NASDAQ.
Latest reported MTB revenue for 2026-06-30 was $860.0M. Net income was $1.48B. MTB currently screens at market cap $30.99B and trailing P/E 11.9.
NMRA does not have a complete income-statement cache yet.
MTB currently screens at market cap $30.99B and trailing P/E 11.9. NMRA currently screens at market cap $283.5M.
Not investment advice. Open the MTB and NMRA stock pages for the full models.
Not investment advice.